AP2013006835A0 - Novel vaccines against the A/H1N1 pandemic flu virus - Google Patents

Novel vaccines against the A/H1N1 pandemic flu virus

Info

Publication number
AP2013006835A0
AP2013006835A0 AP2013006835A AP2013006835A AP2013006835A0 AP 2013006835 A0 AP2013006835 A0 AP 2013006835A0 AP 2013006835 A AP2013006835 A AP 2013006835A AP 2013006835 A AP2013006835 A AP 2013006835A AP 2013006835 A0 AP2013006835 A0 AP 2013006835A0
Authority
AP
ARIPO
Prior art keywords
vaccines against
flu virus
novel vaccines
pandemic flu
pandemic
Prior art date
Application number
AP2013006835A
Other languages
English (en)
Inventor
Lopez Hector Manuel Zepedo
Original Assignee
Zepeda Lopez Hector Manuel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MX2011011561A external-priority patent/MX2011011561A/es
Application filed by Zepeda Lopez Hector Manuel filed Critical Zepeda Lopez Hector Manuel
Publication of AP2013006835A0 publication Critical patent/AP2013006835A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/11—Orthomyxoviridae, e.g. influenza virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16171—Demonstrated in vivo effect

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AP2013006835A 2010-11-02 2011-11-01 Novel vaccines against the A/H1N1 pandemic flu virus AP2013006835A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40930310P 2010-11-02 2010-11-02
MX2011011561A MX2011011561A (es) 2011-10-31 2011-10-31 Vacunas novedosas contra el virus de la influenza pandemica a/h1n1.

Publications (1)

Publication Number Publication Date
AP2013006835A0 true AP2013006835A0 (en) 2013-04-30

Family

ID=48537726

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2013006835A AP2013006835A0 (en) 2010-11-02 2011-11-01 Novel vaccines against the A/H1N1 pandemic flu virus

Country Status (9)

Country Link
EP (1) EP2650362A4 (xx)
JP (1) JP2014511119A (xx)
KR (1) KR20130140050A (xx)
CN (1) CN103328629A (xx)
AP (1) AP2013006835A0 (xx)
BR (1) BR112013010830A2 (xx)
CA (1) CA2826234A1 (xx)
EA (1) EA201300525A1 (xx)
WO (1) WO2012060678A2 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3029629A1 (en) * 2016-04-18 2017-10-26 Emerging Viral Vaccine (HK) Limited Cold adapted and virulence factor deleted live attenuated vaccine suitable for mucosal delivery
WO2019124557A1 (ja) * 2017-12-21 2019-06-27 株式会社グリーンバイオメッド 交差免疫抗原ワクチン及びその調製方法
CA3113647A1 (en) 2018-09-21 2020-03-26 Board Of Regents Of The University Of Nebraska Methods of making and using universal centralized influenza vaccine genes
KR102218980B1 (ko) * 2019-09-18 2021-02-23 한국생명공학연구원 오셀타미비르 내성 인플루엔자 바이러스에 대한 항체
US20240018218A1 (en) * 2020-09-08 2024-01-18 Novelgen Co., Ltd. Antiviral composition against influenza a virus
CN112063726A (zh) * 2020-09-21 2020-12-11 杭州市疾病预防控制中心 一种用于检测奥司他韦耐药突变的引物、探针及检测方法
CN113151408A (zh) * 2021-05-24 2021-07-23 厦门健康工程与创新研究院 一种等温环介导扩增方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
US8080255B2 (en) * 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
AU2005248377B2 (en) * 2004-05-25 2011-03-24 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
AR059972A1 (es) * 2006-03-22 2008-05-14 Solvay Pharm Bv Administracion intranasal o inhalacional de virosomas
MX2013004975A (es) * 2010-11-02 2014-01-17 Opko Pharmaceuticals Llc Vacunas novedosas contra el virus pandémico de la influenza a/h1n1.

Also Published As

Publication number Publication date
CA2826234A1 (en) 2012-05-10
EP2650362A9 (en) 2014-04-09
EP2650362A4 (en) 2014-10-01
EA201300525A1 (ru) 2014-02-28
EP2650362A2 (en) 2013-10-16
BR112013010830A2 (pt) 2017-12-12
JP2014511119A (ja) 2014-05-08
WO2012060678A3 (es) 2012-07-19
CN103328629A (zh) 2013-09-25
WO2012060678A2 (es) 2012-05-10
KR20130140050A (ko) 2013-12-23

Similar Documents

Publication Publication Date Title
IL262123A (en) Influenza virus vaccines and their uses
HRP20180706T1 (hr) Kimerna gripa nalik čestici koja sadrži hemaglutinin
IL261204A (en) Influenza virus vaccines and their use
HK1199211A1 (en) Influenza virus vaccines and uses thereof
EP2758038A4 (en) NEW INFLUENZA HEMAGGLUTININ PROTEIN VACCINES
HK1209646A1 (en) Nasal influenza vaccine composition
EP2552479A4 (en) INFLUENZA VIRUS VACCINES AND USES THEREOF
SG11201402780UA (en) Influenza a virus specific antibodies
DK3447131T3 (da) Influenza a-virusmutanter
HK1200845A1 (en) Influenza hemagglutinin variants
IL229307A0 (en) Inactivated dengue virus vaccine
AP2013006835A0 (en) Novel vaccines against the A/H1N1 pandemic flu virus
IL224022B (en) Thermally stable influenza vaccine
EP2833147A4 (en) INFLUENZA VIRUS DETECTION KIT
ZA201300395B (en) Influenza vaccine
HK1214959A1 (zh) 流感病毒重配
HK1202924A1 (zh) 用於流感病毒血凝素的測定
SG11201503229SA (en) Swine influenza hemagglutinin and neuraminidase variants
GB0918679D0 (en) Influenza vaccine
EP2486054A4 (en) RECOMBINANT ANTIBODIES AGAINST H1N1 INFLUENZA
SG2014010185A (en) Influenza hemagglutinin and neuraminidase variants
EP2424879A4 (en) INFLUENZA VACCINE
HK1177692A1 (zh) 新的流感病毒
EP2749287A4 (en) INHIBITOR OF INFLUENZA VIRUS INFECTION